Pentokey Organy India Ltd (524210)

Pentokey Organy India Ltd has announced its 39th Annual General Meeting (AGM) for the financial year ended March 31, 2026, to be held on September 26, 2026. The company is a micro-cap entity with a market capitalization of ₹21 Cr and a TTM revenue of only ₹2 Cr. Recent quarterly performance has been volatile, with negative revenue reported in the last two quarters of FY26. The meeting will be conducted virtually via video conferencing at 3:00 PM.

• 39th Annual General Meeting scheduled for September 26, 2026, at 3:00 PM
• Board of Directors finalized the meeting date on August 13, 2026
• Company reported a TTM revenue of ₹2 Cr against a market cap of ₹21 Cr
• Promoter holding remains stable at 73.03% as of March 2026
• Meeting to be held via video conferencing/other audio-visual means

Pentokey Organy India Ltd has appointed Ms. Kavita Kailash Bohra as an Additional Director (Non-executive Independent) effective August 13, 2026. Ms. Bohra is a Chartered Accountant with over 8 years of experience in audit, assurance, and corporate governance. This appointment fulfills the regulatory requirement for a woman independent director and is for a fixed term of 5 years, subject to shareholder approval. Given the company's small scale (TTM revenue of Rs 2 Cr), strengthening board oversight is a standard governance step.

• Appointment of Ms. Kavita Kailash Bohra as an Additional Director effective August 13, 2026
• Appointee brings over 8 years of post-qualification experience as a Chartered Accountant
• The term of appointment is fixed for 5 years, pending shareholder ratification
• Ms. Bohra is not related to any existing directors of the company

Pentokey Organy India Ltd approved its standalone unaudited financial results for the quarter ended June 30, 2026, in a board meeting on August 13, 2026. The company is a micro-cap entity with a market capitalization of Rs 21 Cr and a TTM revenue of only Rs 2 Cr. Recent financial performance has been under significant pressure, with the company reporting negative operating margins of -10.5% and volatile revenue figures in previous quarters. While the specific P&L numbers for Q1 FY27 were not detailed in the announcement extract, the company maintains a zero-debt balance sheet.

• Board meeting held on August 13, 2026, to approve Q1 FY27 unaudited results.
• Company operates at a very small scale with TTM revenue of just Rs 2 Cr.
• Promoter holding remains stable and high at 73.03% as of the last reporting cycle.
• The company maintains a zero-debt status (D/E of 0.00) with a net worth of Rs 10 Cr.
• Market capitalization stands at approximately Rs 21 Cr as of the announcement date.

Pentokey Organy (India) Ltd approved its unaudited financial results for the quarter ended June 30, 2026. The company is a micro-cap in the commodity chemicals sector with a market capitalization of only Rs 21 Cr. Recent performance has been under significant pressure, with TTM revenue at just Rs 2 Cr and negative revenue reported in the preceding two quarters (Mar 2026 and Dec 2025). The board meeting was brief, lasting 40 minutes, and the statutory auditors issued a limited review report with no major qualifications mentioned in the summary.

• Board approved unaudited financial results for the quarter ended June 30, 2026
• The board meeting commenced at 12:30 PM and concluded at 01:10 PM
• Company maintains a high promoter holding of 73.03% as per latest context
• TTM revenue is currently low at Rs 2 Cr compared to a market cap of Rs 21 Cr
• Statutory auditors Verma Mehta & Associates completed a limited review of the results

Pentokey Organy India Ltd has scheduled a board meeting for August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is currently in a precarious financial position with a TTM revenue of only Rs 2 Cr and a negative operating margin of 10.5%. Investors should note that the company reported negative revenue in the previous two quarters (Mar 2026: -Rs 1.86 Cr; Dec 2025: -Rs 2.09 Cr), making this upcoming result critical for assessing business viability. The trading window remains closed until 48 hours post-announcement.

• Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
• Results pertain to the three-month period ended June 30, 2026.
• Trading window to reopen 48 hours after the results are made public.
• Company TTM revenue stands at a minimal Rs 2 Cr against a market cap of Rs 24 Cr.
• Previous quarter (Mar 2026) reported a net loss of Rs 0.13 Cr.